^
Association details:
Evidence:
Evidence Level:
Resistant: D – Preclinical
Source:
Title:

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

Published date:
11/04/2020
Excerpt:
BCLW overexpression in aggressive B-cell lymphoma cell lines conferred resistance to the non-specific BH3 mimetic navitoclax as well as to venetoclax.
DOI:
https://doi.org/10.1182/blood-2020-142545